Department of Biochemistry and Molecular Biology

Research output

Research output per year 1973 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

• 920 Article
• 81 Patent
• 38 Review article
• 9 Chapter
• 17 More
  • 6 Comment/debate
  • 5 Conference contribution
  • 4 Editorial
  • 2 Letter

Research output per year

Research output per year

Search results

• 2014

  REGULATOR AND PHARMACEUTICAL COMPOSITION ENCOMPASSING THE REGULATOR

  Chow, N-H., Liu, H-S. & Chang, W-T., 2014 Feb 20, Patent No. 9180139

  Research output: Patent

  • Pharmaceutical 100%

• Treatment of Osteoarthritis Using IL-20 Antagonists

  Chang, M-S., 2014 Jan 23, Patent No. 9221904

  Research output: Patent

  • interleukin 20 100%
  • Osteoarthritis 54%
  • Antibodies 22%

• 人類纖維黏蛋白變異體及其醫藥用途

  Chuang, W-J., 2014 Apr 1, Patent No. I580692

  Research output: Patent
• 2013

  DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF

  Chuang, W-J., 2013 Mar 28, Patent No. HK1136160

  Research output: Patent

  • Disintegrins 100%
  • Integrins 47%
  • Pharmaceutical Preparations 31%
  • Peptides 16%
• 2012

  Disintegrin variants and pharmaceutical uses thereof

  Chuang, W-J., 2012 Mar 30, Patent No. 577998

  Research output: Patent

  • Disintegrins 100%
  • Integrins 47%
  • Pharmaceutical Preparations 31%
  • Peptides 16%

• Disintegrin variants and pharmaceutical uses thereof

  Chuang, W-J., 2012 Mar 30, Patent No. 598176

  Research output: Patent

  • Disintegrins 100%
  • Integrins 47%
  • Pharmaceutical Preparations 31%
  • Peptides 16%

• 一種用於預防或治療心血管疾病之醫藥組合物

  Translated title of the contribution: A PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CARDIOVASCULAR DISEASEWu, H-L., 施桂月, Liu, P-Y., Lin, C-C., Tsai, W-C., Li, Y-H., 林立人 & 陳志鴻, 2012 Sept 11, IPC No. A61K 31/485, Patent No. I372054, 2008 Jan 28, Priority date 2028 Jan 27

  Research output: Patent
• 2011

  COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOGENESIS-RELATED EYE DISEASES

  Chuang, W-J., 2011 Nov 16, Patent No. I581801

  Research output: Patent

• Disintegrin variants and pharmaceutical uses thereof

  Chuang, W-J., 2011 Feb 10, Patent No. 2477727

  Research output: Patent

  • Disintegrins 100%
  • Integrins 47%
  • Pharmaceutical Preparations 31%
  • Peptides 16%

• POLYPEPTIDES SELECTIVE FOR αVβ3 INTEGRIN CONJUGATED WITH A VARIANT OF HUMAN SERUM ALBUMIN (HSA) AND PHARMACEUTICAL USES THEREOF

  Chuang, W-J., 2011 Mar 1, Patent No. I557224

  Research output: Patent

• RNAi compound targeted to thrombospondin-1 and applications thereof

  Lai, M-D., 2011 Jul 7, Patent No. 8377902

  Research output: Patent

  • Pharmaceutical 100%

• Use of Anti-IL-20 antibody for treating rheumatoid arthrits and osteoporosis

  Chang, M-S., 2011 Mar 17, Patent No. 8454956

  Research output: Patent

  • antibody 100%

• Use of Anti-IL-20 antibody for treating rheumatoid arthrits and osteoporosis

  Chang, M-S., 2011 Jan 6, Patent No. 8206712

  Research output: Patent

  • interleukin 20 100%
  • Etanercept 76%
  • Osteoporosis 53%
  • Rheumatoid Arthritis 50%
  • Peptides 38%
• 2010

  Use of Anti-IL-20 antibody for treating osteoporosis (as amended)

  Chang, M-S., 2010 Apr 8, Patent No. 7837994

  Research output: Patent

  • interleukin 20 100%
  • Etanercept 76%
  • Osteoporosis 53%
  • Rheumatoid Arthritis 50%
  • Peptides 38%

• Use of Anti-IL-20 antibody for treating stroke

  Chang, M-S., 2010 Apr 8, Patent No. 8012478

  Research output: Patent

  • interleukin 20 100%
  • Bone Neoplasms 74%
  • Anti-Idiotypic Antibodies 51%
  • Stroke 41%
  • Antibodies 33%
• 2009

  Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases

  Chang, M-S., 2009 Feb 19, Patent No. 7786274

  Research output: Patent

  • interleukin 20 100%
  • Psoriatic Arthritis 36%
  • Antibodies 33%
  • Stomach Ulcer 33%
  • Psoriasis 29%

• Disintegrin variants and pharmaceutical uses thereof

  Chuang, W-J., 2009 Jul 29, Patent No. 153383

  Research output: Patent

  • Disintegrins 100%
  • Integrins 47%
  • Pharmaceutical Preparations 31%
  • Peptides 16%

• Disintegrin variants and pharmaceutical uses thereof

  Chuang, W-J., 2009 Oct 13, Patent No. 291711

  Research output: Patent

  • Disintegrins 100%
  • Integrins 47%
  • Pharmaceutical Preparations 31%
  • Peptides 16%

• DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF

  Chuang, W-J., 2009 Jul 23, Patent No. 60/871,854

  Research output: Patent

  • Disintegrins 100%
  • Integrins 47%
  • Pharmaceutical Preparations 31%
  • Peptides 16%

• DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF

  Chuang, W-J., 2009 Dec 2, Patent No. EP 2124548

  Research output: Patent

  • Disintegrins 100%
  • Integrins 47%
  • Pharmaceutical Preparations 31%
  • Peptides 16%
• 2008

  Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases

  Chang, M-S., 2008 Dec 18, Patent No. 7611705

  Research output: Patent

  • interleukin 20 100%
  • Psoriatic Arthritis 36%
  • Antibodies 33%
  • Stomach Ulcer 33%
  • Psoriasis 29%

• DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF

  Chuang, W-J., 2008 Aug 7, Patent No. 7943728

  Research output: Patent

  • Disintegrins 100%
  • Integrins 47%
  • Pharmaceutical Preparations 31%
  • Peptides 16%
• 2006

  interleukin-20,monoclonal antibody 7e, and uses thereof

  Chang, M-S., 2006 Jun 29, Patent No. 7435800

  Research output: Patent

  • interleukins 100%
  • monoclonal antibodies 75%
  • antibodies 55%
  • bones 35%
  • neoplasms 32%
• 2005

  DNA vaccine containing tumor-associated gene and cytokine ene and method of preparation

  Lai, M-D., 2005 Jan 27, Patent No. 7132407

  Research output: Patent

  • Cytokines 50%
  • Genetic Recombination 39%
  • Genes 33%
  • Neoplasms 26%
  • DNA 22%
• 1800

  A DNA VACCINE CONTAINING A TUMOR ASSOCIATED GENE AND A CYTOKINE GENE AND THE METHOD PRODUCING THEREOF

  Lai, M-D., 1800, Patent No. I259206

  Research output: Patent

• Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases

  Chang, M-S., 1800, Patent No. 特許第5167408號

  Research output: Patent

  • interleukin 20 100%
  • Bone Neoplasms 74%
  • Anti-Idiotypic Antibodies 51%
  • Antibodies 33%

• APPLICATION OF IRON-GOLD CORE-SHELL NANOPARTICLES IN TUMOR THERAPEUTICS

  Wu, C-L., Yeh, C-S., Chen, D-H., Chou, C-H. & Shieh, D-B., 1800, Patent No. I295177

  Research output: Patent

• Complex for preparing influenza vaccine, novel influenza vaccine, and method for manufacturing the same

  Wu, C-L., Shiau, A-L. & Chen, Y-H., 1800, Patent No. I493038

  Research output: Patent

• Disintegrin variants and pharmaceutical uses thereof

  Chuang, W-J., 1800, Patent No. I392738

  Research output: Patent

• DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF

  Chuang, W-J., 1800, Patent No. 8183201

  Research output: Patent

  • Disintegrins 100%
  • Integrins 71%
  • Pharmaceutical Preparations 31%
  • Proteins 18%
  • Peptides 16%

• GALECTIN-1-GOLD PARTICLE COMPLEX AND APPLICATIONS THEREOF

  Wu, C-L., Shiau, A-L. & Wang, C-R., 1800, Patent No. I466894

  Research output: Patent

• HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF

  Chang, M-S., 1800, Patent No. 8597647

  Research output: Patent

  • interleukin 20 100%
  • Antibodies, Monoclonal, Humanized 39%
  • Antibodies 33%
  • Disclosure 33%
  • Osteoporosis 26%

• HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF

  Chang, M-S., 1800, Patent No. 9217031

  Research output: Patent

  • interleukin 20 100%
  • Antibodies, Monoclonal, Humanized 39%
  • Antibodies 33%
  • Disclosure 33%
  • Osteoporosis 26%

• Method and biomarker for evaluating cancer metastasis, and siRNA compound for inhibiting cancer metastasis

  Liao, P-C. & Cheng, H-C., 1800, Patent No. I484183

  Research output: Patent

• Method for preparation of water-soluble and dispersed iron oxide nanoparticles and application thereof

  Wu, C-L., Yeh, C-S. & Shieh, D-B., 1800, Patent No. 202070

  Research output: Patent

• Method for Preparation of Water-Soluble and Dispersed Iron Oxide Nanoparticles and Application Thereof

  Wu, C-L., Yeh, C-S. & Shieh, D-B., 1800, Patent No. 10 2004 035 803

  Research output: Patent

• METHODS FOR TREATING OSTEOPOROSIS WITH ANTI-IL-20 RECEPTOR ANTIBODIES

  Chang, M-S., 1800, Patent No. 9127066

  Research output: Patent

  • interleukin-20 receptor 100%
  • Osteoporosis 45%
  • Antibodies 28%
  • interleukin 20 21%
  • Diabetic Nephropathies 13%

• PHARMACEUTICAL CARRIER FOR RECOGNIZING CARCINOMA AND PHARMACEUTICAL COMPOSITION FOR TREATING CARCINOMA

  Cheng, H-C., 1800, Patent No. I463992

  Research output: Patent

• PHARMACEUTICAL COMPOSITION FOR DIAGNOSING CARCINOMA METASTASIS

  Cheng, H-C., 1800, Patent No. I532995

  Research output: Patent

• PHARMACEUTICAL COMPOSITION FOR INHIBITING THE FUNCTION OF VASCULAR ENDOTHELIAL.

  Wu, C-L., 1800, Patent No. I369209

  Research output: Patent

• Polypeptide for inhibiting metastasis, use thereof, and pharmaceutical composition containing the same

  Cheng, H-C., 1800, Patent No. I472337

  Research output: Patent

• POLYPEPTIDES SELECTIVE FOR αVβ3 INTEGRIN CONJUGATED WITH A VARIANT OF HUMAN SERUM ALBUMIN (HSA) AND PHARMACEUTICAL USES THEREOF

  Chuang, W-J., 1800, Patent No. AR077764A1

  Research output: Patent

• Regulator And Pharmaceutical Composition Encompassing The Regulator

  Chow, N-H., Liu, H-S. & Chang, W-T., 1800, Patent No. ZL 2013 1 0177660.2

  Research output: Patent

  • Pharmaceutical 100%

• REGULATOR AND PHARMACEUTICAL COMPOSITION ENCOMPASSING THE REGULATOR

  Chow, N-H., Liu, H-S. & Chang, W-T., 1800, Patent No. I474819

  Research output: Patent

• Treating allergic airway disorders using anti-IL-20 receptor antibodies

  Chang, M-S., 1800, Patent No. 8852588

  Research output: Patent

  • interleukin-20 receptor 100%
  • Airway Obstruction 54%
  • Asthma 40%
  • Antibodies 28%

• Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody

  Chang, M-S., 1800, Patent No. 8535674

  Research output: Patent

• Treating Breast Cancer with Anti-IL-19 Antibody

  Chang, M-S., 1800, Patent No. 8377441

  Research output: Patent

  • antibodies 57%

• Treating Breast Cancer with Anti-IL-19 Antibody

  Chang, M-S., 1800, Patent No. 8377441

  Research output: Patent

• Treating Breast Cancer With Anti-IL-19 Antibody

  Chang, M-S., 1800, Patent No. 2600896

  Research output: Patent

  • antibodies 57%

• Treating Breast Cancer With Anti-IL-19 Antibody

  Chang, M-S., 1800, Patent No. 2600896

  Research output: Patent